Trademark: 97805943
Word
EXCELLOS
Status Date
Tuesday, July 2, 2024
Registration Number
7431789
Registration Date
Tuesday, July 2, 2024
Filing Date
Wednesday, February 22, 2023
Published for Opposition
Tuesday, April 16, 2024
40 bio-manufacturing for others, namely, manufacturing of adoptive cell and personalized adoptive cell therapies
39 distributing human blood products for others, namely, transportation of blood products for others; Storage and retrieval of blood, peripheral blood mononuclear cells (PBMCs), tissue and stem cells for scientific, laboratory, and medical research
5 Pharmaceutical preparations for immunotherapy, namely, mononuclear cells, progenitor cells, and antibody preparations for medical purposes
1 Cells and biological tissue, namely, blood, lymphocytes, T cells, stem cells, and T cell receptors for use in scientific, laboratory, and medical research; Cell growth media for growing cells for scientific and research use; reagents for scientific and research use for tissue digestion, cell isolation, cell storage, cell population expansion and amplification, cell growth and cell stimulation; reagents for scientific and research use for white blood cell and lymphocyte isolation, cell storage, white blood cell and lymphocyte population expansion and amplification, and white blood cell and lymphocyte growth and stimulation; lymphocytes in the nature of cells for scientific and research use; living tissue in the nature of chimeric antigen receptor (CAR-T) cells for clinical trial, scientific, laboratory, and medical research; Biological reagents for scientific and medical research use; Biological preparations, namely, mononuclear cells, progenitor cells, and antibody preparations for use in medical clinical trials and medical research in the field of immunotherapy
44 Medical services, namely, processing of stem cells and white blood cells for use by others; stem cell and white blood cell storage, namely, stem cell and white blood cell bank services; collection and preservation of human blood, blood components, apheresis, peripheral blood mononuclear cells (PBMCs), plasma and bone marrow
42 Medical research, namely research in the field of the blood process of patients' blood to isolate lymphocytes for the use in immunotherapy for therapeutic medical research
Feb 25, 2023
New Application Entered
Mar 13, 2023
New Application Office Supplied Data Entered
Nov 21, 2023
Assigned To Examiner
Nov 21, 2023
Non-Final Action Written
Nov 21, 2023
Non-Final Action E-Mailed
Nov 21, 2023
Notification Of Non-Final Action E-Mailed
Jan 4, 2024
Teas Response To Office Action Received
Jan 4, 2024
Correspondence Received In Law Office
Jan 4, 2024
Teas/Email Correspondence Entered
Jan 8, 2024
Examiners Amendment -Written
Jan 8, 2024
Examiners Amendment E-Mailed
Jan 8, 2024
Notification Of Examiners Amendment E-Mailed
Jan 8, 2024
Examiner's Amendment Entered
Jan 8, 2024
Approved For Pub - Principal Register
Jan 23, 2024
Withdrawn From Pub - Og Review Query
Mar 7, 2024
Previous Allowance Count Withdrawn
Mar 8, 2024
Examiners Amendment -Written
Mar 8, 2024
Examiners Amendment E-Mailed
Mar 8, 2024
Notification Of Examiners Amendment E-Mailed
Mar 8, 2024
Examiner's Amendment Entered
Mar 8, 2024
Approved For Pub - Principal Register
Mar 27, 2024
Notification Of Notice Of Publication E-Mailed
Apr 16, 2024
Published For Opposition
Apr 16, 2024
Official Gazette Publication Confirmation E-Mailed
Jul 2, 2024
Registered-Principal Register
Jul 2, 2024
Notice Of Registration Confirmation Emailed
Trademark Alertz updated from USPTO on 2030-01-24
